ARWR Insider Trading Activity and SEC Form 4 Filings
Trump's trades in ARWR
From his financial disclosures
-
0 purchases
$100K+
1 sale
Sale
Feb 9, 2026
Reported 94d later
$100K - $250K
Many orders in these accounts are placed by the account manager.
ARWR insider trading summary
Over the past 12 months, insiders at Arrowhead Pharmaceuticals, Inc. (ARWR) reported 57 sales worth $31.6M by 9 insiders and no open-market purchases on SEC Form 4. Net insider selling was $31.6M.
Latest ARWR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Michael S Perry | Director | Sell | $1.0M (11,600 @ $87.30) |
| Aug 18, 2026 | Adeoye Y Olukotun | Director | Sell | $174K (2,000 @ $86.96) |
| May 12, 2026 | Hongbo Lu | Director | Sell | $228K (2,970 @ $76.88) |
| Mar 5, 2026 | James C Hamilton | Chief Medical Officer | Sell | $642K (10,000 @ $64.19) |
| Jan 5, 2026 | James C Hamilton | Chief Medical Officer | Sell | $283K (4,625 @ $61.24) |
| Jan 5, 2026 | James C Hamilton | Chief Medical Officer | Sell | $77K (1,200 @ $64.49) |
| Jan 5, 2026 | James C Hamilton | Chief Medical Officer | Sell | $379K (6,090 @ $62.28) |
| Jan 5, 2026 | James C Hamilton | Chief Medical Officer | Sell | $932K (14,792 @ $63.01) |
| Jan 5, 2026 | James C Hamilton | Chief Medical Officer | Sell | $813K (12,711 @ $63.95) |
| Jan 5, 2026 | James C Hamilton | Chief Medical Officer | Sell | $29K (437 @ $65.97) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.